Author: therawinformant

The Altium Limited (ASX: ALU) share price could be on the move on Tuesday after the release of a sales update for FY 2020.

How did Altium perform in FY 2020?

As per its prior updates, Altium fell short of its aspirational revenue target of US$200 million in FY 2020. This was due to the negative impact of the pandemic on its sales performance at the end of the financial year.

According to the release, for the 12 months ended 30 June 2020, the electronic design software company delivered a 10% increase in revenue to US$189 million. This means Altium has now recorded eight consecutive years of double digit revenue growth.

Altium’s solid top line growth was driven by robust performances across core business units and key regions during the challenging COVID-19 environment.

The key Altium Designer platform recorded a 14% increase in new seats sold and a 17% lift in its subscription base to well over 50,000 subscribers.

At the end of the period Altium had a cash balance of over US$90 million. This compares to US$80.5 million a year earlier.

Management commentary.

Altium’s CEO, Aram Mirkazemi, was pleased with the company’s performance in these difficult trading conditions.

He commented: “Altium’s strategy of providing attractive pricing and extended payment terms to support our customers during COVID-19 and to drive volume to support our pursuit of market dominance has been rewarded. Altium achieved strong growth in new Altium Designer seats and record growth in our subscription base to reach well over 50,000 seats on subscription.”

And although the chief executive was disappointed that Altium didn’t achieve its aspirational revenue target, he believes a lot of progress has been made towards future goals.

“While COVID-19 prevented us from reaching our long standing aspirational goal of $200 million in revenue, conditions surrounding COVID-19 have dramatically accelerated our movement towards market dominance and the implementation of our transformative agenda for the industry,” explained Mr Mirkazemi.

This was thanks largely to its launch of the new cloud platform Altium 365, which allows engineers to work from anywhere and connect with anyone. At the end of the period, there were 2,500 companies using Altium 365 and almost 5,000 active users.

Outlook.

No guidance was given for FY 2021. However, the company continues to target 100,000 subscribers and market dominance by 2025.

Further details will be provided with the release of its full year results in August.

Mr Mirkazemi commented: “At our full year results, we will share more color on the long-term impact of COVID-19 on the acceleration of our strategy of market dominance and industry transformation. We will also share color about our recurring revenue and pricing model post COVID-19 and based on the impact of Altium 365.”

More reading

• 3 ASX shares to buy for the next decade
• Why the RPMGlobal share price could be a bargain buy right now
• 3 ASX shares that I’d invest $1,000 into EVERY month
• Fund managers have been buying Costa and this ASX 200 share
• Why buying Altium shares could make you rich

James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. owns shares of Altium. The Motley Fool Australia has no position in any of the stocks mentioned. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

The post Altium share price on watch following FY 2020 sales update appeared first on Motley Fool Australia.

from Motley Fool Australia https://ift.tt/30lOG6L

Of all the industry sectors represented on the ASX, the ASX healthcare sector is definitely one of my favourites. Our ageing population is driving an ever-increasing demand for healthcare services. Also, continual technology advances in this market segment is driving demand higher.

In this article we examine 2 of my top ASX healthcare shares right now: ResMed Inc (ASX: RMD) and Nanosonics Ltd. (ASX: NAN). I am attracted to both of them because of their high level of technological innovation, entrenched market positions, and growing international exposure.

I believe both have strong long-term growth potential, which is likely to translate to above average shareholder returns over the next 5 years.

Nanosonics

ASX healthcare company Nanosonics manufactures and distributes disinfection system for ultrasound probes. Nanosonic’s core product, the trophon EPR disinfection system, has achieved an industry reputation as the leader in its market niche.

Nanosonics has seen strong revenue growth over the past 5 years. In particular, the company has continued to see solid revenue growth in its largest market, the US. It also has been experiencing strong growth across Asia, Europe and the Middle East. Nanosonics achieved total revenue of $48.5 million for the first half of FY20. This was an increase of 19% on the prior corresponding period (pcp).

In its most recent market update, the company revealed that sales momentum has continued during the early phase of the coronavirus pandemic. Unaudited sales for the third quarter of FY20 were significantly higher than the prior corresponding period. However, lower than anticipated overall growth of its installed base is predicted for Q4, due to difficulty accessing some hospitals.

Despite any short-term challenges, I believe that Nanosonics is well placed to grow strongly over the next 5 years, on the back of the growing global trend towards stricter disinfection control in hospitals.

ResMed

Another ASX healthcare share that I would consider adding to your share portfolio is ResMed. The company designs and manufactures healthcare devices and cloud-based software solutions for sleep apnea and other respiratory conditions.

Revenue growth over the past few years has been assisted by new product launches and successful targeted acquisitions. ResMed’s global scale and entrenched market position provide it with a strong competitive advantage. ResMed recorded a super strong 47% increase in net income during the third quarter of FY20.

I believe that the demand for ResMed’s products will continue over the next decade. Research from ResMed estimates that around 1 billion people globally are impacted by sleep apnoea worldwide. In addition, more than 80% of cases are estimated to be undiagnosed globally.

More reading

• Why I think the Polynovo share price is a buy right now
• These ASX growth shares could be market-beaters during the 2020s
• Why Domino’s and Nanosonics shares could be fantastic buy and hold options
• Altium and these ASX 200 shares could be quality buy and hold options
• 3 high quality ASX 100 shares to buy right now

Phil Harpur owns shares of Nanosonics Limited and ResMed Inc. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. owns shares of Nanosonics Limited. The Motley Fool Australia has recommended Nanosonics Limited and ResMed Inc. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

The post Nanosonics and 1 more ASX healthcare share to buy and hold beyond 2025 appeared first on Motley Fool Australia.

from Motley Fool Australia https://ift.tt/32dfRD1

The Pushpay Holdings Ltd (ASX: PPH) share price will be on watch today after it revealed that a major shareholder will be selling down its stake.

What did Pushpay announce?

This morning Pushpay announced that shareholders associated with the Huljich family have entered into a block trade agreement with J.P. Morgan and UBS New Zealand to sell 25% of their shares in the donor management system provider.

According to a separate notice, the sellers agreed a price of at least NZ$8.60 per share for the 14,406,494 shares, which represents a total sale price of ~NZ$123.9 million.

This represents a 7% discount to the last close price of Pushpay’s New Zealand listed shares.

Despite the sizeable sale of shares, the Huljich family is expected to remain the largest shareholder of Pushpay with a combined relevant interest in 43.2 million shares.

Pushpay also revealed that the Huljich family remains strongly committed to Pushpay. Peter Huljich will remain on the Pushpay board, with Christopher Huljich continuing to act as his Alternate Director.

Peter Huljich commented: “The outlook for Pushpay remains positive. We look forward to continuing to support the Company as it seeks to deliver upon its strategy of becoming the preferred provider of mission-critical software to the US faith sector.”

“The Huljich family confirms that it does not have any current intention to sell further shares in Pushpay and has provided an undertaking to the Underwriters not to sell further shares in Pushpay until after Pushpay’s FY21 Interim Results are announced on the NZX and ASX,” he concluded.

What now?

News like this doesn’t often go down well with the market and I wouldn’t be surprised to see the Pushpay share price drop lower today. In fact, in early trade in New Zealand the company’s shares are down over 6%.

However, I feel this could be an overreaction. Given how the Huljich family still has a substantial stake in the company, their interests are still firmly aligned with shareholders.

And given Pushpay’s extremely bright long term outlook, any notable share price weakness could arguably be a buying opportunity for investors.

More reading

• The difficulty of investing in shares right now
• The rise and rise of ASX SaaS shares
• Pushpay and 1 other ASX tech share to buy right now
• 3 ASX shares that I’d invest $1,000 into EVERY month
• Why the Pushpay share price soared 19% in June

James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. owns shares of PUSHPAY FPO NZX. The Motley Fool Australia has recommended PUSHPAY FPO NZX. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

The post Why the Pushpay share price could tumble lower today appeared first on Motley Fool Australia.

from Motley Fool Australia https://ift.tt/2Wigwzn

The terms growth and pandemic may not go hand in hand, however many sectors have flourished amid COVID-19.

Here are 2 high growth ASX 200 shares that could present themselves as excellent investment opportunities in the current climate. 

Pointsbet Holdings Ltd (ASX: PBH) 

Spending on gambling has been on the rise amid the COVID-19 crisis. The Sydney Morning Herald reports that NAB’s internal bank data on consumer spending showed expenditure on gambling had increased by 50.7% since the start of the year. This could spell good news for ASX 200 gambling shares such as Tabcorp Holdings Limited (ASX: TAH), Jumbo Interactive Ltd (ASX: JIN) and Pointsbet. 

I believe that Pointsbet is in a strong position to grow its business both domestically and in the US. The return of the AFL and NRL seasons will see the breadth of Pointsbet product offering expand in Australia. Its exclusive deal with Fox Sports AFL during the 2020 season is also a boon for Pointsbet’s Australian trading business.

The US sports betting market is still in its infancy, with many states still pending sports betting legalisation. The return of the PGA (golf) season and anticipated recommencement of both NBA and MLB seasons should see an increased turnover for Pointsbet in the coming months.

The company has also recently signed a deal with BetMakers Technology Group Ltd (ASX: BET) to begin fixed odds betting on horseracing in the New Jersey market. New Jersey has been one of the pioneers for fixed odds sports betting in the US, with its latest sports betting annual turnover reported at more than $4.5 billion. 

Zip Co Ltd (ASX: Z1P) 

Zip’s acquisition of Quadpay could be transformative for the company’s growth moving forward. This acquisition will immediately add Quadpay’s existing 1.5 million customers, 3,500 merchants and an annualised $900 million transaction value to Zip’s metrics. More importantly, this acquisition allows the company to enter the US market.  

Quadpay itself is a simple product that allows customers to pay in 4 instalments spread over 6 weeks, interest free. What takes the Quadpay product to the next level is its “Anywhere” app, enabling customers to pay in instalments in-store or online at any merchant. This makes the product highly scalable and minimises integration costs.

From a valuation perspective, I believe Zip, post-Quadpay acquisition, represents much better value than other ASX 200 buy now, pay later shares such as Afterpay Ltd (ASX: APT). However, given its recent share price spike, I wouldn’t be in a hurry to buy Zip shares but rather will watch closely for a buying opportunity. 

More reading

• Are these small cap ASX shares future tech stars?
• The difficulty of investing in shares right now
• ASX shares tapping into the US market
• Can the Afterpay share price go higher from here?
• ASX 200 Weekly Wrap: Rocketing BNPL shares fail to stop ASX 200 slide

Lina Lim has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. owns shares of Pointsbet Holdings Ltd and ZIPCOLTD FPO. The Motley Fool Australia owns shares of AFTERPAY T FPO. The Motley Fool Australia has recommended Pointsbet Holdings Ltd. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

The post 2 high growth ASX 200 shares to buy with $10,000 amid the coronavirus pandemic appeared first on Motley Fool Australia.

from Motley Fool Australia https://ift.tt/3gWIUPk

At the time of writing the gold price is sitting slightly above the US$1,800 barrier for the first time since 2011.

Gold is a hedge against chaos. That is because when things go really bad for an extended duration, then the gold price rises while equities fall. So too, gold mining shares.

For example, since the start of the year the Evolution Mining Ltd (ASX: EVN) share price has risen by 63.47%. Consequently, it is currently trading at a price-to-earnings ratio (P/E) of 38.16. This is astronomical for a mining company.

To illustrate the point, Fortescue Metals Group Limited (ASX: FMG) is performing well as a company, yet is trading at a P/E of 6.61. BHP Group Ltd (ASX: BHP), the world’s largest mining company, has a P/E of 13.87.

So, is the gold price too high to invest in? 

Investing in gold

If you are going to invest in ASX gold shares, then its important to understand a few basic concepts.

First, only about 48% of gold is used in jewellery. Approximately 44% is bought by investors, including central banks, and the rest finds its way into technological equipment.

Second, about 80% of all the gold we know about is above the ground. So in a gold rush, we have more and more people chasing smaller and smaller reserves of gold. Moreover, gold is not only rare on earth, it is one of the rarest metals in the universe – gold and other precious metals are formed at the moment a star goes supernova. 

Third, and importantly for investors, ASX gold mining shares do not pay significant dividends. 

In summary, the gold price is driven by investor demand, so it can fall as quickly as it rises, and the benefit for investors in a gold mining company is share price growth, because there aren’t many dividends to speak of. 

Where are the bargains?

Personally, I don’t think there are many bargains to be found in the established gold miners right now. As stated, Evolution Mining has a P/E of 38.16. Northern Star Resources Ltd (ASX: NST) has a P/E of 48.37. Even Newcrest Mining Limited (ASX: NCM) has a P/E of 31.97.

Will these share prices rise further? Probably. Particularly during earnings season when Northern Star and Saracen Mineral Holdings Limited (ASX: SAR) announce what they have been able to achieve with the recently acquired Kalgoorlie Consolidated Gold Mine, or Superpit. 

But who knows for how long, or how high? Or, for that matter, how far they will fall when the gold price suddenly snaps back (if it ever snaps back).

Enter the explorers

My preference for commodities investing, just like any other form of investing, is to buy a company I can keep for a long time. That means buying a gold explorer at a point where it has a solid reserve and is ready to start moving to the producing phase. 

Personally, I have purchased Bellevue Gold Ltd (ASX: BGL) shares. With its Bellevue gold project in Western Australia, the company is sitting on possibly the highest grade gold deposit in the world today. Not only that, but it is in an area that has been previously mined. As such, the costs for infrastructure are going to be low, and the gold depth is less than many other deposits in Australia.

The company recently raised $100 million via institutional placement, and is raising another $20 million via a share placement with retail shareholders (you and I). This is for project acceleration, so, more exploration, mine development and non-process infrastructure.

Foolish takeaway

At this stage in the gold price cycle, the established gold miners are very expensive, but in my view the gold explorers remain a good investing option. I have shown why I bought Bellevue, but there are a range of others also. For example, the Yamarna Terrane of the eastern Yilgarn by Gold Road Resources (ASX: GOR) and the Red 5 Limited (ASX: RED) King of the Hills gold deposit, as well as a raft of micro caps.

More reading

• 5 things to watch on the ASX 200 on Tuesday
• Why the Fortescue share price rallied over 40% to a record high in 2020
• 3 ASX shares with incredible cost moats
• How does the Fortescue share price compare to its peers?
• A great ASX dividend share to buy this week

Motley Fool contributor Daryl Mather owns shares of Bellevue Gold Ltd and Fortescue Metals Group Limited. The Motley Fool Australia has no position in any of the stocks mentioned. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

The post Is the gold price too high for investing in ASX gold shares? appeared first on Motley Fool Australia.

from Motley Fool Australia https://ift.tt/2DBwZrT

S&P/ASX 200 Index (ASX: XJO) blue chip shares are good options to help deliver long-term returns and stability for your portfolio in my opinion.

Blue chips are seen as safer shares and are usually the leaders in their industry. Some people may think that blue chips have low growth potential. I think that’s true about some blue chips like BHP Group Ltd (ASX: BHP) and Woolworths Group Ltd (ASX: WOW) that are already huge players, but there are other blue chips that I think are good long-term buy ideas:

A2 Milk Company Ltd (ASX: A2M)

A2 Milk is one of the leading infant formula businesses. The company continues to grow its market share in the key China market. In the FY20 half-year result A2 Milk said that it grew its China infant formula market share from 5.4% in December 2018 to 6.6% in December 2019.

The company has remained resilient in the face of the COVID-19 pandemic with people stocking up on A2 Milk’s products. The business is high quality and the products are also seen as high quality. I think quality will win out during this pandemic. 

The ASX 200 share saw such strong trading that its earnings before interest, tax, depreciation and amortisation (EBITDA) margin is now expected to be in the range of 31% to 32%, rather than the goal of 30%. I think that shows that as the business grows its margins can improve further.

It’s steadily growing its market presence in the US and China, which should allow for bigger profits over the years. Plus, there are plenty of other countries like Canada to generate earnings from in the future.

At the current A2 Milk share price, it’s trading at 30x FY22’s estimated earnings.

Wesfarmers Ltd (ASX: WES)

I think Wesfarmers could be one of the best examples of an ASX 200 blue chip share available to Aussies.

It was set up in 1914, so it clearly has excellent longevity. The business is now largely a retail conglomerate with subsidiaries that are leaders in their respective fields. Bunnings, Officeworks and Kmart have proven to be very good businesses. The acquisition of online retailer Catch seems like a really smart move in hindsight.

I like that Wesfarmers is willing to acquire businesses in new industries to improve its earnings profile and add more diversification to the business. The Kidman Resources deal was a good example of this – lithium clearly has a compelling future, but it was quite brave to move into a new industry.

The ASX 200 share is also willing to divest businesses if it no longer makes sense to own them such as the decision to sell the Curragh coal mine.

At the current Wesfarmers share price, it’s trading at 25x FY22’s estimated earnings with a grossed-up dividend yield of 4.75%.

Washington H. Soul Pattinson and Co. Ltd (ASX: SOL)

Soul Patts is one of the oldest businesses on the ASX. It has been listed since 1903. If that isn’t good staying power I don’t know what is.

The ASX 200 share started off as a pharmacy business – which is where the name of the chain of Soul Pattinson chemists comes from – but it has since turned into a multi-billion investment conglomerate. Australian Pharmaceutical Industries Ltd (ASX: API) is now the operator of the Soul Pattinson chemists. And Soul Patts is a major shareholder of API.

Soul Patts also owns shares of other businesses like TPG Telecom Ltd (ASX: TPG), Brickworks Limited (ASX: BKW), Clover Corporation Limited (ASX: CLV) and Bki Investment Co Ltd (ASX: BKI).

The great thing about Soul Patts is that, like Wesfarmers, it can change its investments over time to future-proof itself. This ability to change its portfolio makes Soul Patts a ‘forever’ share in my opinion, rather than just a long-term idea.

It’s currently working on investing in a new industry – regional data centres. This could prove to be a timely investment with the ongoing COVID-19 pandemic causing a shift to working from home for plenty of workers.

At the current share price, Soul Patts offers a grossed-up dividend yield of 4.3%.

Foolish takeaway

I really like all three of these ASX 200 blue chip shares. A2 Milk may be able to generate the biggest returns over the next five years as its global expansion continues. But I think I like the idea of owning Soul Patts shares the most due to its defensive portfolio and ultra-long-term investment outlook.

More reading

• 5 things to watch on the ASX 200 on Tuesday
• Why the Appen share price gained 53% in the first half of 2020
• Fund manager warns that ASX bank dividends facing multi-year bad debt hit
• Why the Domino’s share price gained 30% in the first half of 2020
• The difficulty of investing in shares right now

Tristan Harrison owns shares of Washington H. Soul Pattinson and Company Limited. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. owns shares of Clover Limited. The Motley Fool Australia owns shares of and has recommended Brickworks and Washington H. Soul Pattinson and Company Limited. The Motley Fool Australia owns shares of A2 Milk and Wesfarmers Limited. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

The post 3 top ASX 200 blue chip shares to buy appeared first on Motley Fool Australia.

from Motley Fool Australia https://ift.tt/2DyqTZi

I think some ASX shares would make great candidates to buy and hold for the next decade.

Over the long-term it’s beneficial for your wealth if you can avoid over-trading your share portfolio. Each transaction you make incurs brokerage and each crystallised gain triggers a capital gains tax event. You want to avoid these types of costs where possible.

But you don’t want to be left holding a dud ASX share for years either. I think it’s important to invest in great shares to start off with and just enjoy the ride.

That’s why I think these three ASX shares would be great ideas to buy and own them for the next decade:

Share 1: Bubs Australia Ltd (ASX: BUB)

At the moment Bubs is my favourite small cap ASX share idea. The company is displaying all of the right attributes to generate strong returns over the next decade.

For a long-term idea I like to see a large potential total addressable market that the company is only just beginning to tap. The infant formula ASX share is growing in China, Vietnam and I’m sure it has it’s aiming for other Asian countries with consumers that want high-quality products. In 10 years we may see Bubs sold in places like North America or even Europe.

I also want to see that the company is growing its profit margin. Economies of scale is another factor for delivering strong profit growth. In the FY20 half-year result the company saw its gross margin increase from 19% to 24%. In June 2018 the gross margin was just 14%.

The other factor I like to see is effective leadership. Bubs has done a really good job of expanding its domestic and international distribution channels as well as securing its supply chain, particularly with the Deloraine manufacturing facility acquisition.

I’d like to buy shares at the current Bubs share price.

Share 2: Altium Limited (ASX: ALU)

Altium has been one of my preferred long-term ASX share ideas for quite a while.

The ongoing COVID-19 pandemic is definitely going to cause a hit to margins and profit in FY20. The upcoming US election may also cause a lot of volatility, particularly if Joe Biden wins and reverses the recent US corporate tax cut.

But the ASX ideas in this article are for a 10-year investment, not 10 months.

I believe Altium is one of the brightest prospects on the ASX. The electronic PCB software business is still aiming for global market leadership by 2025. I think it was a smart move to try to keep growing market share over the last few months, rather than trying to protect short-term profit margins.

The world is getting increasingly technological and Altium is an important part of that. Some of its clients include Google, Apple, Tesla, Space X, Amazon, Disney and so on. These are high-quality clients to have.

Altium’s balance sheet is in a strong position with no debt. It hasn’t needed to do a capital raising like a lot of other mid-caps on the ASX over the past six months.

I think the ASX share has quality and focused management that can turn the business into a global leader by 2030, if not much earlier.

At the current Altium share price it’s trading at 49x FY22’s estimated earnings.

Share 3: Magellan Global Trust (ASX: MGG)

Magellan Global Trust is one of the best listed investment trusts (LITs) out there in my opinion. It’s operated by the high-performing Magellan Financial Group Ltd (ASX: MFG), with rich lister Hamish Douglass at the helm.

The ASX share aims to invest in the highest-quality global shares that it can find. At the moment those names include picks like Alibaba, Alphabet, Atmos Energy, Microsoft, Tencent, Facebook, Visa, Mastercard, Reckitt Benckiser and Novartis.

It regularly outperforms its global benchmark after fees and targets a distribution of 4% of its net asset value (NAV).

At the current Magellan Global Trust share price it’s possible to buy this LIT at a small discount to its NAV, which is attractive in my opinion.

Over the next decade I think this ASX share could generate solid net returns.

Foolish takeaway

I think all three of these ASX shares are quality ideas which can outperform the ASX over the next decade. However, I’m a bit nervous of what may happen in the US due to COVID-19 impacts and the upcoming election, so whilst I’d be happy to buy Altium and Magellan Global Trust shares today, an even better price could come up later this year. I’d pick Bubs first at today’s share price.

More reading

• Bubs and 1 other exciting small cap ASX share to buy
• Why the RPMGlobal share price could be a bargain buy right now
• My ASX share for the week
• 3 ASX shares that I’d invest $1,000 into EVERY month
• 2 fantastic ASX growth shares to buy with $2,000

Tristan Harrison owns shares of Altium and MAGLOBTRST UNITS. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. owns shares of Altium. The Motley Fool Australia owns shares of and has recommended BUBS AUST FPO. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

The post 3 ASX shares to buy for the next decade appeared first on Motley Fool Australia.

from Motley Fool Australia https://ift.tt/38UwOnc